Sun Pharma Advanced Research Company (SPARC) today reported Rs 62.57 crore loss for the second quarter ended September 30, 2017-18.
The company had posted net profit of Rs 15.01 crore for the corresponding period of the previous fiscal, SPARC said in a filing to BSE.
The total income of the company stood at Rs 16.35 crore for the quarter under consideration. It was Rs 98.93 crore for the same period year ago.
SPARC stock closed 6.85 per cent up at Rs 379.60 on BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content
